Emergent BioSolutions Inc (EBS)
5.70
+0.61
(+11.98%)
USD |
NYSE |
May 31, 16:00
5.72
+0.02
(+0.35%)
After-Hours: 20:00
Emergent BioSolutions Gross Profit (Quarterly): 147.80M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 147.80M |
December 31, 2023 | 84.80M |
September 30, 2023 | 87.20M |
June 30, 2023 | 140.70M |
March 31, 2023 | 4.90M |
December 31, 2022 | 102.60M |
September 30, 2022 | 75.30M |
June 30, 2022 | 65.60M |
March 31, 2022 | 142.00M |
December 31, 2021 | 430.00M |
September 30, 2021 | 94.60M |
June 30, 2021 | 144.30M |
March 31, 2021 | 222.40M |
December 31, 2020 | 380.60M |
September 30, 2020 | 210.30M |
June 30, 2020 | 241.30M |
March 31, 2020 | 93.00M |
December 31, 2019 | 203.40M |
September 30, 2019 | 168.20M |
June 30, 2019 | 101.40M |
March 31, 2019 | 77.10M |
December 31, 2018 | 130.80M |
September 30, 2018 | 86.10M |
June 30, 2018 | 118.40M |
March 31, 2018 | 47.60M |
Date | Value |
---|---|
December 31, 2017 | 115.57M |
September 30, 2017 | 88.70M |
June 30, 2017 | 45.15M |
March 31, 2017 | 53.28M |
December 31, 2016 | 70.88M |
September 30, 2016 | 71.85M |
June 30, 2016 | 29.02M |
March 31, 2016 | 47.34M |
December 31, 2015 | 100.53M |
September 30, 2015 | 93.61M |
June 30, 2015 | 63.62M |
March 31, 2015 | 11.79M |
December 31, 2014 | 76.91M |
September 30, 2014 | 61.47M |
June 30, 2014 | 52.95M |
March 31, 2014 | 19.50M |
December 31, 2013 | 66.25M |
September 30, 2013 | 56.23M |
June 30, 2013 | 48.65M |
March 31, 2013 | 24.66M |
December 31, 2012 | 59.20M |
September 30, 2012 | 43.78M |
June 30, 2012 | 39.98M |
March 31, 2012 | 26.85M |
December 31, 2011 | 22.64M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
4.90M
Minimum
Mar 2023
430.00M
Maximum
Dec 2021
157.02M
Average
141.35M
Median
Gross Profit (Quarterly) Benchmarks
Avid Bioservices Inc | 2.383M |
Viking Therapeutics Inc | -- |
FibroGen Inc | 30.15M |
Geron Corp | -- |
MAIA Biotechnology Inc | -- |